Geyser Brands (TSXV:GYSR) Founder Brad Kersch believes that the acquisition of Solace provides the company with a brand portfolio that consumers will fall in love with.

Solace owns several cannabis brands that are already sold across Canada with products for humans and pets. Solace was recently awarded its natural health product number (NPN) from Health Canada. This allows the company to sell its products in brick and mortar pharmacies, health-food stores and grocery stores.

Now that Geyser Brands has acquired Solace, Geyser intends to bring the company to the international marketplace through its partners in Japan, the UK and the US. Geyser Brands plans to work with its partners to produce and distribute the company’s products into mainstream channels.


Silver Outlook 2021

Silver Price Outlook, Top Stocks and More! Download today!

According to Kersch, Geyser Brands is also looking to capitalize on the growing beverages market. Kersch feels that the market could be an “amazing opportunity” for the company and its nano-emulsion technology. So far, the company has developed two beverage formulations that cover the sports drinks and recreational sectors.

Below is a transcript of our interview with Geyser Brands founder Brad Kersch. It has been edited for clarity and brevity.

Investing News Network: What’s your name, company and ticker symbol?

Geyser Brands Founder Brad Kersch: I’m Brad Kersch, the founder and Chairman of Geyser Brands. Our ticker symbol is GYSR on the TSXV.

INN: Please provide our investor audience an overview of Geyser Brands and its global brand strategy.

BK: Geyser is a brand company. We have great Canadian brands that we want to introduce to the rest of the world. Our strategy is to take our most-loved Canadian brands and introduce them through our partners in Japan, the UK and the US where possible. Our brands are hemp-based and cover pet and human products. We work with our partners to produce and distribute our products into mainstream channels.

INN: How is the acquisition of Solace beneficial to Geyser Brands?

BK: With the acquisition of Solace, Geyser has acquired several recognized and in-market brands that are offered nationwide through several major retailers such as Shoppers Drug Mart, PetSmart and Bosley’s. These brands include Apothecary Naturals, Apawthecary Pets, WildTails and Apothecary Ink. Our newly awarded NPN number for our pain gel allows us to sell that product across Canada in brick and mortar pharmacies, health-food stores and grocery stores. It allows us to be first in the market.

INN: What role will Apothecary Brands play in Geyser Brands’ story moving forward?

BK: Apothecary Brands are front-end brands, and we’re developing more brands within their portfolio, like our recently announced SToND line. SToND is our premium hemp line that will be found in high-end spas, makeup counters and pharmacies. These products not only help tell Geyser’s story but also shows it. We are demonstrating that we care about and support our brands.

INN: What’s next for Geyser Brands, and how does that fit into the company’s long term goals?

BK: We are a health and wellness company, and next on the docket is beverages. We feel that beverages are going to be an amazing opportunity for us and our nano-emulsion technology. We have different types of beverages ranging from sports to recreational. Our products not only have to be functional but also taste good. People have to come back, buy that product again and fall in love with it. I think our acquisition of Solace gives us that.

This interview is sponsored by Geyser Brands (TSXV:GYSR). This interview provides information which was sourced by the Investing News Network (INN) and approved by Geyser Brands in order to help investors learn more about the company. Geyser Brands is a client of INN. The company’s campaign fees pay for INN to create and update this interview.

INN does not provide investment advice and the information on this profile should not be considered a recommendation to buy or sell any security. INN does not endorse or recommend the business, products, services or securities of any company profiled.

The information contained here is for information purposes only and is not to be construed as an offer or solicitation for the sale or purchase of securities. Readers should conduct their own research for all information publicly available concerning the company. Prior to making any investment decision, it is recommended that readers consult directly with Geyser Brands and seek advice from a qualified investment advisor.

This interview may contain forward-looking statements including but not limited to comments regarding the timing and content of upcoming work programs, receipt of property titles, etc. Forward-looking statements address future events and conditions and therefore involve inherent risks and uncertainties. Actual results may differ materially from those currently anticipated in such statements. The issuer relies upon litigation protection for forward-looking statements. Investing in companies comes with uncertainties as market values can fluctuate.

Trulieve to donate $20,000 in scholarship funding and $15,000 to support leadership development

Trulieve Cannabis Corp . (CSE: TRUL) (OTC: TCNNF), a leading and top-performing cannabis company in the United States today announced a new partnership with the Thurgood Marshall College Fund (TMCF), the nation’s largest organization exclusively representing the Black College Community. Trulieve will donate $20,000 to help fund several college scholarships awarded to students who are attending one of the organization’s member-schools as part of Trulieve’s diversity, equity, and inclusion initiatives. The $15,000 in talent funding is earmarked to support TMCF’s internship program, reaching a diverse talent pool of students and alumni from their 47 member-schools to provide immersive experiences at Trulieve.

Keep reading... Show less

The new dispensary expands patient access to Florida’s largest inventory of medical cannabis products

Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company based in the United States announced today the opening of a brand-new Florida dispensary, the Company’s 80th nationwide. The new location marks the Company’s first in Tamarac and third in Broward County expanding patient access to Florida’s largest and broadest assortment of high-quality medical cannabis products.

Keep reading... Show less

Revive Therapeutics Ltd. (“Revive” or the “Company”) (CSE: RVV, USA: RVVTF), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, is pleased to announce an update on the Company’s U.S. Food & Drug Administration (“FDA”) Phase 3 clinical trial (the “Study”) to evaluate the safety and efficacy of Bucillamine in patients with mild to moderate COVID-19.

With its recent $23 million dollar financing, the Company plans to aggressively expand from 14 clinical sites to up to 50 clinical sites to meet the next enrollment goals for the Study in Q2-2020. The Study is a randomized, double-blinded, placebo-controlled trial and the safety and efficacy data analyzed at each interim analysis timepoint of 210, 400, 600 and 800 completed patients are only made available to the Independent Data and Safety Monitoring Board (“DSMB”) for review and recommendations on continuation, stopping or changes to the conduct of the Study. In the event of any serious safety concerns, the DSMB would be notified to determine any risks and provide its recommendations. To date, in this initial 210 interim point there have been no serious safety concerns that required the DSMB to be notified.

Keep reading... Show less

HempFusion Wellness Inc. (TSX:CBD.U) (OTCQX:CBDHF) (FWB:8OO) (“HempFusion” or the “Company”), a leading health and wellness CBD company utilizing the power of whole-food hemp nutrition, is pleased to announce that its common shares have been approved for DTC full-service eligibility in the United States by the Depository Trust Company (“DTC”) and can now be both traded and serviced through DTC’s electronic book-entry system.

DTC is a subsidiary of the Depository Trust & Clearing Corp. (“DTCC”) that provides clearing and settlement services for the financial markets and settles the majority of securities transactions in the United States. This electronic method of clearing securities speeds up the receipt of stock and cash and thus accelerates the settlement process for investors and brokers, enabling the stock to be traded over a much wider selection of brokerage firms.

Keep reading... Show less

CFN Enterprises Inc. (OTCQB: CNFN) (CFN Media) partners with FMW Media Works LLC to produce a regular series on the global cannabis markets to air on major financial news networks across the US. Initial segment features leading cannabis analyst and US Multi-State Operator (MSO)

CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the leading media network dedicated to the global legal cannabis, CBD and psychedelics industries, today announced that its inaugural news segment on the cannabis markets, “Cannabis Market Outlook for 2021,” will air on Bloomberg, Newsmax and Fox Business.

Keep reading... Show less